Posts Tagged ‘genomics’
FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial
Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…
Read MoreConsidering New Direct-to-Consumer Breast Cancer Tests? First, Get the Facts
Tiffani A. DeMarco, MS, LCGC, is a licensed and certified genetic counselor and the manager of the cancer genetic counseling program at the Inova Translational Medicine Institute. She and her team of cancer genetic counselors specialize in counseling patients and family members at risk for hereditary cancers. The U.S. Food and Drug Administration (FDA) recently gave…
Read MoreLooking to Technology to Improve Access & Deliver Better Healthcare
Amit Rastogi, MD, is senior vice president for strategy, growth and innovation at Inova. He serves as Inova’s principal medical innovation leader and oversees strategy development across the Inova system. Imagine a man who is experiencing a headache. He attributes his headache to skipping his morning coffee. However, his health-tracking wearable device indicates his…
Read MoreImmunotherapy: Cancer Care Gets Customized
Timothy L. Cannon, MD, is board certified in medical oncology and hematology, and has a special interest in managing gastrointestinal cancers. Dr. Cannon is the clinical director and moderator of Inova’s weekly molecular tumor board, which matches patients with targeted therapies based on molecular diagnostics. Tiffani A. DeMarco, MS, CGC, is a board-certified…
Read MoreWant to get your genome sequenced? At Inova, you’ll soon be able to. Washington Business Journal
The Northern Virginia health giant’s new partnership will give consumers a glimpse into their DNA. Read more.
Read MoreInova Center for Personalized Health Announces Forum on Policy and Ethics Issues in Precision Medicine on Sept. 8
Fairfax, VA – Inova Center for Personalized Health (ICPH) announced today it will host the first-ever Precision Medicine Policy and Ethics Conference on Sept. 8, 2017 at Inova Center for Personalized Health in Fairfax, Va. The conference is a forum for national and industry leaders to address the most pressing challenges in the clinical adoption…
Read MorePrenatal Planning: Do You Need Antenatal Testing?
Alfred N. Khoury, MD, is a maternal-fetal medicine specialist at The Antenatal Testing Center at Inova Women’s Hospital and Inova Loudoun Hospital Antenatal Testing Center. He is board-certified in maternal-fetal medicine and obstetrics and gynecology. Pregnancy is an exciting and often nerve-wracking time. But if there are concerns or complications, the The Antenatal Testing Center…
Read MoreTwo Va. research powerhouses come together on projects with seed fund, Washington Business Journal
Inova Health System and University of Virginia are kicking off their new partnership with $450,000 in seed money to fund nine joint research projects geared toward better predicting, preventing and treating disease. Read more.
Read MoreUVA, Inova award research seed funding grants to joint research teams
The Inova Health System (Inova) and the University of Virginia (UVA) announced today that they have awarded $450,000 to nine UVA-Inova joint research teams for projects focused on how to better predict, prevent and treat disease. In the fall of 2016, Inova and UVA announced a comprehensive research and education partnership to accelerate joint discovery…
Read MoreBRCA Testing Gets a Lot of Attention. Is It Right For You?
Amanda Schott, MS, is a clinical cancer genetic counselor at the Inova Translational Medicine Institute (ITMI). Read Amanda Schott’s profile. The Washington Post recently published a profile of Alejandra Campoverdi, a former White House staffer who decided to run for Congress in her native Los Angeles. While she didn’t win that nomination, Campoverdi is making…
Read More